The 20 Best Pancreatoblastoma Doctors in Texas, US

Dr. Kimberly Washington is fellowship-trained in hepato-pancreato-biliary surgery with vast experience in the surgical and non-surgical treatment of liver, pancreas and biliary tract disorders. She uses a variety of techniques, including minimally invasive laparoscopy, endoscopy, ablation and robotic-assisted approaches, in the management of benign pancreatic masses, acute/chronic pancreatitis and pancreatic cysts. She is also trained in the management of hepatocellular carcinoma, cholangiocarcinoma and all liver metastatic diseases. Additionally, she treats benign diseases of the liver and biliary tract, including hepatic adenomas, liver hemangiomas, polycystic liver disease, simple and complex biliary stone disease, and bile duct injuries.Dr. Washington earned her medical degree and completed general surgery residency at the University of Tennessee in Memphis. She then served the Arlington, Texas community as a board-certified general surgeon from 2014 until 2020. In 2020, she returned to training in hepato-pancreato-biliary surgery fellowship at Oregon Health & Science University in Portland.In addition to her dedication to the management of surgical disease, Dr. Washington has also served on a global scale, caring for patients in India, Peru, Guatemala and Kenya. She has and continues to serve on numerous regional and national committees to advance the treatment of hepato-pancreato-biliary diseases. Dr Washington has published peer-reviewed works on areas of special interest, including multi-disciplinary management of colorectal liver metastasis with node-negative primary disease and surgical management of breast cancer liver metastasis, presenting many of these published works at national and international meetings. Through her role as a faculty member with the TCU Burnett School of Medicine, Dr. Washington was recognized in 2024 with the Gachman Endowed Faculty Excellence Award. She is a member of the American College of Surgeons, Americas Hepato-Pancreato-Biliary Association, American Pancreatic Association, Association of Women Surgeons, International Hepato-Pancreato-Biliary Association, Society of Surgical Oncology and Society for Surgery of the Alimentary Tract. Dr. Washington is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. Her top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatic Pseudocyst, Pancreatectomy, and Liver Embolization.

Herbert Zeh Iii is a General Surgeon and an Oncologist in Dallas, Texas. Dr. Zeh Iii is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Pancreatectomy, and Small Bowel Resection.

Dhiresh Jeyarajah is a General Surgeon in Richardson, Texas. Dr. Jeyarajah is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Hiatal Hernia, Hernia, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Jason Fleming is a Surgical Oncologist and a General Surgeon in Dallas, Texas. Dr. Fleming is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Small Bowel Resection.

Dr. Tom Shires is a Fellow of the American College of Surgeons and sits on their Board of Governors. He specializes in hepatic, pancreatic and biliary surgery. He has followed in the footsteps of his surgeon father, who was a leading researcher and pioneer in the areas of trauma and burn care. Dr. Shires currently serves as the John P. Thompson Chair for Surgical Services at Texas Health Presbyterian Hospital Dallas and on the hospital's Board of Trustees. He also sits on numerous committees, including Texas Health Dallas' Medical Executive Committee and Surgical Services Committee.Dr. Shires graduated with honors from Duke University School of Medicine in Durham, N.C., and completed his general surgery residency training at Emory University School of Medicine in Atlanta, Ga. He was the Harvey Cushing Research Fellow at Cornell University Medical College New York Presbyterian Hospital and the Daniel Elkin Clinical Fellow at Emory.He has decades of experience in the use of advanced and minimally invasive surgical techniques. He previously served as Chief of Surgery at Zale-Lipshy University Hospital in Dallas and as Chairman of the GI and Endocrine Division at The University of Texas Southwestern Medical Center, also in Dallas. Dr. Shires is an avid lecturer, author, medical editor and medical reviewer. Dr. Shires' special interest in surgical education shows through in his role as the residency program director for surgery residents at Texas Health Dallas.Dr. Shires is an active member of such organizations as the North Texas Chapter of the American College of Surgeons, American Hepato Pancreato Biliary Association, The Society for Surgery of the Alimentary Tract, Surgical Infection Society and Association for Academic Surgery. Dr. Shires is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Insulinoma, Pancreatectomy, and Hernia Surgery.

Jeffrey Lamont is a General Surgeon and a Surgical Oncologist in Plano, Texas. Dr. Lamont is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Dr. McCollum specializes in medical oncology and hematology. His clinical and research interests focus on cancers of the gastrointestinal tract, including colon cancer, rectal cancer, esophageal and stomach cancer, and pancreatic cancer. Dr. McCollum is a Diplomate of the American Board of Internal Medicine with subspecialty certifications in hematology and medical oncology. Dr. McCollum has served on the Board of Texas Oncology and is a member of the Scientific Planning Committee of Texas Oncology and the Gastrointestinal Cancers Committee of The US Oncology Network. Recipient of a 2001 Merit Award from the American Society of Clinical Oncology for research presented at the annual meeting. Dr. Mccollum is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Colorectal Cancer.

Aravind Sanjeevaiah, MD is board-certified and fellowship training in Hematology and Oncology. After his fellowship training, he spent 3 years practicing in Anchorage, Alaska where he treated many patients with gastrointestinal cancers. His patients in Alaska presented him with unique clinical, social, and logistical challenges, which motivated him to cultivate an interest in GI oncology. He brought this interest in GI oncology to his previous practice where he ran clinical trials, trained medical students, residents, and fellows, and performed research in addition to treating patients with GI cancers. Dr. Sanjeevaiah is married to a fellow physician and has 3 children. In his spare time, he enjoys running, hiking, and spending time with his family at the beach. Dr. Sanjeevaiah is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Colorectal Cancer, Stomach Cancer, Neuroendocrine Tumor, and Gastrointestinal Stromal Tumor.

Prajnan Das is a Radiation Oncologist in Houston, Texas. Dr. Das is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Stomach Cancer, Anal Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Endoscopy.

Emma Holliday is a Radiation Oncologist in League City, Texas. Dr. Holliday is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. Her top areas of expertise are Anal Cancer, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Stomach Cancer.

Shaalan Beg is an Oncologist in Dallas, Texas. Dr. Beg is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Pancreatoblastoma, Familial Pancreatic Cancer, and Familial Colorectal Cancer.

Lei Zheng is an Oncologist in San Antonio, Texas. Dr. Zheng is rated as a Distinguished provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatoblastoma, and Pancreatic Ductal Adenocarcinoma.

Patricio Polanco is a Surgical Oncologist and a General Surgeon in Dallas, Texas. Dr. Polanco is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

David D'spain is an Oncologist in Granbury, Texas. Dr. D'spain is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, B-Cell Lymphoma, and Familial Colorectal Cancer.

Laith Abushahin is an Oncologist in Dallas, Texas. Dr. Abushahin is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Familial Colorectal Cancer.

Matthew Porembka is a Surgical Oncologist and a General Surgeon in Dallas, Texas. Dr. Porembka is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Stomach Cancer, Pancreatic Cancer, Ampullary Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Houssam Osman is a General Surgeon in Richardson, Texas. Dr. Osman is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Hiatal Hernia, Hernia, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Asha Karippot is a Hematologist and an Oncologist in Plano, Texas. Dr. Karippot is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, and Paget Disease of the Breast.

Erin Fleener, MD, is dedicated to delivering high-quality, compassionate care to Bryan and nearby communities. Erin Fleener specializes in Oncology and works at Cancer Clinic. To make an appointment, please call (979) 776-2000. Dr. Fleener is rated as an Advanced provider by MediFind in the treatment of Pancreatoblastoma. Her top areas of expertise are Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Familial Colorectal Cancer, and Colorectal Cancer.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Pancreatoblastoma. His top areas of expertise are Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.